Total Payments
$345,059
2024 Payments
$2,560
Companies
44
Transactions
608
Medicare Patients
1,848
Medicare Billing
$191,733
Payment Breakdown by Category
Other$245,646 (71.2%)
Consulting$45,570 (13.2%)
Research$21,388 (6.2%)
Travel$16,955 (4.9%)
Food & Beverage$15,499 (4.5%)
Education$1.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $222,699 | 68 | 64.5% |
| Consulting Fee | $45,570 | 20 | 13.2% |
| Honoraria | $22,947 | 9 | 6.7% |
| Unspecified | $21,388 | 9 | 6.2% |
| Travel and Lodging | $16,955 | 47 | 4.9% |
| Food and Beverage | $15,499 | 454 | 4.5% |
| Education | $1.00 | 1 | 0.0% |
Payments by Type
General
$323,671
599 transactions
Research
$21,388
5 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Covidien LP | $198,648 | 179 | $0 (2020) |
| Boston Scientific Corporation | $77,131 | 102 | $0 (2023) |
| GI Supply, Inc. | $16,923 | 6 | $0 (2022) |
| Eli Lilly and Company | $12,396 | 4 | $0 (2023) |
| Bausch Health US, LLC | $8,992 | 1 | $0 (2022) |
| Medtronic, Inc. | $8,889 | 24 | $0 (2024) |
| Aries Pharmaceuticals, Inc. | $6,698 | 10 | $0 (2018) |
| Micro-tech Endoscopy USA, Inc. | $5,000 | 4 | $0 (2022) |
| Mauna Kea Technologies, Inc. | $4,726 | 8 | $0 (2017) |
| ABBVIE INC. | $1,359 | 125 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,560 | 135 | Laborie Medical Technologies Corp. ($599.77) |
| 2023 | $4,270 | 69 | Medtronic, Inc. ($3,290) |
| 2022 | $14,708 | 49 | Bausch Health US, LLC ($8,992) |
| 2021 | $16,815 | 36 | GI Supply, Inc. ($11,041) |
| 2020 | $23,995 | 19 | Eli Lilly and Company ($9,787) |
| 2019 | $29,228 | 47 | Covidien LP ($24,045) |
| 2018 | $117,676 | 113 | Covidien LP ($84,963) |
| 2017 | $135,807 | 140 | Covidien LP ($81,178) |
All Payment Transactions
608 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.44 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/17/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.20 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $2.28 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.39 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $0.73 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.98 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.65 | General |
| Category: GI | ||||||
| 11/26/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/19/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $5.34 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.03 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Medtronic, Inc. | ENDOFLIP (Device) | Food and Beverage | In-kind items and services | $39.43 | General |
| Category: Motility Testing | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | Laborie Medical Technologies Corp. | alpHaONE (Device) | Food and Beverage | Cash or cash equivalent | $16.79 | General |
| Category: Gastroenterology | ||||||
| 10/24/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.95 | General |
| Category: Neuroscience | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STUDY COMPARING THE EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS PLACEBO IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH) | Eli Lilly and Company | $12,347 | 3 |
| A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis | Bausch Health US, LLC | $8,992 | 1 |
| A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 2 STUDY COMPARING THE EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS PLACEBO IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH) | Eli Lilly and Company | $48.50 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 574 | 774 | $309,436 | $58,885 |
| 2022 | 13 | 406 | 451 | $200,915 | $41,623 |
| 2021 | 12 | 409 | 466 | $195,165 | $42,248 |
| 2020 | 12 | 459 | 509 | $200,501 | $48,976 |
Total Patients
1,848
Total Services
2,200
Medicare Billing
$191,733
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 50 | 50 | $53,029 | $10,064 | 19.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 54 | 100 | $14,600 | $6,024 | 41.3% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 33 | 36 | $18,318 | $5,487 | 30.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 54 | $11,718 | $4,586 | 39.1% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 17 | 110 | $16,720 | $3,999 | 23.9% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $12,120 | $3,901 | 32.2% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 33 | 33 | $29,361 | $3,723 | 12.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 57 | $8,436 | $3,439 | 40.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 16 | 60 | $6,000 | $2,901 | 48.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $8,632 | $2,849 | 33.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 92 | 98 | $71,094 | $2,836 | 4.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 26 | $7,228 | $2,662 | 36.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 19 | 19 | $7,809 | $2,587 | 33.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 45 | 45 | $38,178 | $1,916 | 5.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,628 | $871.60 | 33.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 15 | 15 | $2,265 | $647.42 | 28.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 13 | $1,300 | $391.41 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 79 | $17,143 | $6,777 | 39.5% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 37 | 37 | $18,167 | $6,366 | 35.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 29 | 29 | $30,790 | $5,548 | 18.0% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 20 | 20 | $11,540 | $4,053 | 35.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 90 | 96 | $67,792 | $4,018 | 5.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 48 | $7,104 | $2,949 | 41.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $6,972 | $2,440 | 35.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $6,165 | $2,384 | 38.7% |
About Dr. Gary Reiss, MD
Dr. Gary Reiss, MD is a Gastroenterology healthcare provider based in Marrero, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1568666543.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Reiss, MD has received a total of $345,059 in payments from pharmaceutical and medical device companies, with $2,560 received in 2024. These payments were reported across 608 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($222,699).
As a Medicare-enrolled provider, Reiss has provided services to 1,848 Medicare beneficiaries, totaling 2,200 services with total Medicare billing of $191,733. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Marrero, LA
- Active Since 06/13/2007
- Last Updated 08/12/2014
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1568666543
Products in Payments
- Barrx (Device) $51,631
- Beacon (Device) $26,595
- RESOLUTION CLIP (Device) $19,446
- SPYGLASS (Device) $17,151
- PillCam (Device) $11,796
- EverLift Submucosal Lifting Agent (Device) $10,009
- XIFAXAN (Drug) $9,117
- Covidien (Device) $8,345
- DREAMWIRE (Device) $7,176
- ELEVIEW (Device) $6,698
- CAPTIVATOR (Device) $5,560
- GENERAL - THERAPIES (Device) $4,708
- WALLFLEX (Device) $4,500
- GENERAL - BILIARY DEVICES (Device) $4,439
- Tri-Staple (Device) $3,850
- GENERAL THERAPIES (Device) $3,837
- Emprint (Device) $3,600
- GENERAL HEMOSTASIS (Device) $2,645
- THERAPIES (Device) $2,572
- All Products (Device) $1,750
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Marrero
Dr. Scott Pollack, M.d, M.D
Gastroenterology — Payments: $44,501
Gastroenterology $44,501
Dr. Shantiprakash Kedia, M.d, M.D
Gastroenterology — Payments: $11,746
Gastroenterology $11,746
Dr. Sanjeeva Reddy, M.d, M.D
Gastroenterology — Payments: $9,527
Gastroenterology $9,527
Brett Hymel, Md, MD
Gastroenterology — Payments: $6,171
Gastroenterology $6,171
James Campbell, Md, MD
Gastroenterology — Payments: $5,534
Gastroenterology $5,534
Dr. Charles Schibler, M.d, M.D
Gastroenterology — Payments: $3,046
Gastroenterology $3,046